ESTABLISHING A CLINICALLY RELEVANT MODEL OF MESENCHYMAL GLIOBLASTOMA (GBM) TO STUDY RESPONSE TO STANDARD OF CARE TREATMENT AND IMMUNE CHECKPOINT INHIBITION (ICI).

Clerkin, J; Connor, K; Sweeney, K; White, K; Shiels, L; Maher, S; Marignol, L; Prehn, JHM; O'Brien, D; Byrne, A

NEURO-ONCOLOGY, 2020; 22 (): 230

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索